3

OWNERSHIP DOCUMENT

Company: 4D Molecular Therapeutics, Inc.
Filed: December 10, 2020
Period of Report: December 10, 2020
Accession Number: 0001387131-20-010839

View Document ↗ View on SEC.gov ↗